Molly McGlauglhinSenior Vice President and Global Lead, Biologics CDMO at BioLexis
Ms McGlaughlin has over 27 years’ experience in the Biotechnology industry in both developing Biologic manufacturing business units and licensing and partnering technology. She has a solid P&L performance and business strategy track record. Ms McGlaughlin has held positions on the management team of Eirgenix, Natrix Separations, BioVectra, Selexys S.A., Cytovance Biologics, Avecia Biotechnology (Now Fuji Diosynth), Patheon, and Mallinckrodt. Molly holds a BS in Biology from Norwich University, Military College of Vermont, a Masters in Organizational Performance Improvement from University of Massachusetts, Boston, Masters in Strategic Studies from the U.S. Army War College, and is completing her dissertation in the School of Business and Technology at Capella University where her doctoral studies focus on M&A in the Biotechnology Industry. Molly is also a long-time member of the U.S. Army Reserves where she holds the rank of Colonel and Commands a Brigade of 350 Soldiers.